ABOUT OUR FOUNDER
Pinaki R. Majhi, Ph.D.
Office: (508) 659-7002
Dr. Pinaki Majhi founded Unicus Pharmaceuticals in May 2017. Dr. Majhi is a highly experienced product development professional with strong background in pharmaceutical and colloid chemistry (23+ years of combined research and product development experience in US, Germany, and India). He has expertise in product development (concept-to-launch) including pre-formulation, formulation design & optimization, and scale-up of topical, oral, ophthalmic, and personal care products. He is skilled in formulation and characterization of semi-solid, suspension, and liquid dosage forms and designing novel drug delivery/platform technologies. Dr. Majhi was involved with 120+ product development, reformulation, scale-up or manufacturing projects related to personal skincare, Rx/OTC topical (dermatological, optic, and ophthalmic), Rx/OTC oral liquid (e.g. cold & cough products), oral liquid supplements, and other products.
Prior to Unicus Pharmaceuticals, Pinaki held R&D & Technical Operations positions for several pharmaceutical and personal care companies including Denison Pharmaceuticals, Amneal Pharmaceuticals, PreCision Dermatology, Valeant Pharmaceuticals NA, Dow Pharmaceutical Sciences, and Assam Company Limited. At Denison Pharmaceuticals, Dr. Majhi has been instrumental in founding new R&D Division and CRO business and converting Denison from CMO to CDMO (Contract Development Manufacturing Organization).
Dr. Majhi holds a Ph.D. degree in Chemistry (Colloids, Pharmaceuticals) from Jadavpur University (India) and received postdoctoral training on lipid (vesicles), protein and nucleic acid chemistry from several universities in Germany and USA including Martin Luther University of Halle-Wittenberg (Germany), Indiana University-Purdue University Indianapolis, and University of California San Francisco. He has published 65+ publications (including research articles, patents, conference abstracts, and a book chapter) so far.
Arijit Bose, Ph.D.
Dr. Arijit Bose is Distinguished Professor of Engineering and Professor of Chemical Engineering at the University of Rhode Island (URI). His current research encompasses colloidal and interfacial engineering, with specific efforts in nanostructured materials synthesis and characterization for lithium ion battery anodes, advanced applications (biological and non-biological) for cryogenic transmission and scanning electron microscopy, and particle-stabilized emulsions. Prof. Bose has 120 peer-reviewed publications, and holds 8 US patents. He has been presented twice with the URI College of Engineering’s Vincent and Estelle Murphy Award for outstanding research, and URI’s intellectual property award. He was an Associate Editor of the IEEE Transactions in Nanotechnology form 2003-2008, and serves on the editorial board of the Journal of Surface Science and Technology.
Professor Bose served as Chair of the Department of Chemical Engineering at University of Rhode Island from 2004-2009. He has been a Visiting Scientist at MIT (1989; 1995-96), a Visiting Senior Scientist/ Visiting Fellow at Cabot Corporation (2002-2004; 2009-2010) and a Visiting Professor at UC Berkeley (2017). Professor Bose has a B. Tech. in Chemical Engineering from the Indian Institute of Technology, Kanpur, and a Ph.D. from the University of Rochester.
Peter B. Dragone, MBA
Mr. Peter Dragone has spent the past six years as an acting/consulting CFO for a number of start-ups in industries ranging from CPG, Health and Wellness, and SaaS. Peter’s prior experience is that of a serial entrepreneur, managing various start-up and turnaround projects. He was a co-founder of Keurig, Inc., now the multi-billion dollar Keurig/Green Mountain Inc. Before starting Keurig, Mr. Dragone was a senior financial/operational manager for Chiquita Brands International. He has an MBA from Harvard Business School, an MA (in Spanish) from Middlebury College and a BA from Colby College.
Interested in joining our team, please check out here